By Paul L
Shares of Sonnet BioTherapeutics (NASDAQ: SONN) soared in pre-market trading on Monday after the company announced a $888 million business … Continue reading
The post This stock rockets 260% after $900 million mega crypto deal appeared first on Finbold.